Health Canada authorized Novavax COVID-19 vaccine
On Feb. 17, 2022, Novavax announced that Health Canada had granted authorization for Nuvaxovidï¾™ COVID-19 Vaccine (Recombinant protein,…
On Feb. 17, 2022, Novavax announced that Health Canada had granted authorization for Nuvaxovidï¾™ COVID-19 Vaccine (Recombinant protein,…
On Mar. 6, 2020, the Government of Canada announced an investment of nearly $27 million to fund Coronavirus…